Deposition of fibrillar amyloid -protein (A) in the brain is a prominent pathological feature of Alzheimer disease and related disorders, including familial forms of cerebral amyloid angiopathy (CAA). Mutant forms of A, including Dutch-and Iowa-type A, which are responsible for familial CAA, deposit primarily as fibrillar amyloid along the cerebral vasculature and are either absent or present only as diffuse non-fibrillar plaques in the brain parenchyma. Despite the lack of parenchymal fibril formation in vivo, these CAA mutant A peptides exhibit a markedly increased rate and extent of fibril formation in vitro compared with wild-type A. Based on these conflicting observations, we sought to determine whether brain parenchymal factors that selectively interact with and modulate CAA mutant A fibril assembly exist. Using a combination of immunoaffinity chromatography and mass spectrometry, we identified myelin basic protein (MBP) as a prominent brain parenchymal factor that preferentially binds to CAA mutant A compared with wild-type A. Surface plasmon resonance measurements confirmed that MBP bound more tightly to Dutch/Iowa CAA double mutant A than to wild-type A. Using a combination of biochemical and ultrastructural techniques, we found that MBP inhibited the fibril assembly of CAA mutant A. Together, these findings suggest a possible role for MBP in regulating parenchymal fibrillar A deposition in familial CAA.
Extracellular deposition of amyloid -protein (A)2 in the brain is a prominent feature of Alzheimer disease and other related disorders (1). A is a 39 -43-amino acid peptide that exhibits a high propensity to self-assemble into -sheet-containing oligomeric forms and fibrils (2). A peptides are proteolytically produced from the amyloid -protein precursor (APP), a large type I integral membrane protein, through sequential proteolysis by -and ␥-secretase activities (3-6). Cerebral deposition of A in the parenchyma can occur as diffuse plaques, with little surrounding pathology, or as fibrillar plaques associated with dystrophic neurons, neurofibrillary tangles, and inflammation (1). Fibrillar A deposition also occurs within and along primarily small and medium arteries and arterioles of the cerebral cortex and leptomeninges and in the cerebral microvasculature, a condition known as cerebral amyloid angiopathy (CAA) (7-9). This condition accounts for up to 20% of all spontaneous primary intracerebral hemorrhages and is a key pathological lesion in nearly all patients with Alzheimer disease and certain related disorders. Accumulation of fibrillar cerebral vascular A has been shown to cause degeneration and cell death of smooth muscle cells and pericytes in affected larger cerebral vessels and cerebral microvessels, respectively (9 -11). Recent findings have implicated cerebral microvascular A deposition in promoting neuroinflammation and dementia in Alzheimer disease (12-15).There exist several familial monogenic forms of CAA resulting from specific point mutations within the A seque...